1、Yan DW, Fan JW, Yu ZH, Li MX, Wen YG, Li DW, Zhou CZ, Wang XL, Wang Q, Tang HM, Peng ZH. Downregulation of Metallothionein 1F, a putative oncosuppressor, by loss of heterozygosity in colon cancer tissue. Biochim Biophys Acta,2012;1822(6):918-926
2、Wang X, Yan D*, Teng M, Fan J, Zhou C, Li D, Qiu G, Sun X, Li T, Xing T, Tang H, Peng X, Peng Z. Reduced Expression of PER3 Is Associated with Incidence and Development of Colon Cancer. Ann Surg Oncol,2012;Feb 17.[Epub ahead of print]
3、Fan J, Yan D*, Teng M, Tang H, Zhou C, Wang X, Li D, Qiu G, Peng Z. Digital Transcript Profile Analysis With aRNA-LongSAGE Validates FERMT1 as a Potential Novel Prognostic Marker for Colon Cancer. Clin Cancer Res,2011;17(9):2908-18.
4、Li D, Peng X, Yan D*, Tang H, Huang F, Yang Y, Peng Z. Msi-1 is a predictor of survival and a novel therapeutic target in colon cancer. Ann Surg Oncol,2011;18(7):2074-83.
5、严东旺,王权,李大卫,温玉刚,唐华美,彭志海. MT1F基因过表达重组质粒构建及转染结肠癌RKO细胞的鉴定. 中华实验外科杂志,2011;28(12):2162-2164.
6、王权,温玉刚,唐华美,严东旺#,彭志海. 胃癌17号染色体抑癌基因候选区域精细定位分析. 中华实验外科杂志,2011;28(12):2148-2151.
7、Yan DW, Li DW, Yang YX, Xia J, Wang XL, Zhou CZ, Fan JW, Wen YG, Sun HC, Wang Q, Qiu GQ, Tang HM, Peng ZH. Ubiquitin D is correlated with colon cancer progression and predicts recurrence for stage II-III disease after curative surgery. Br J Cancer,2010;103(7):961-69.
8、严东旺,李大卫,周崇治,樊军卫,唐华美,彭志海 . 胰岛素样生长因子ⅡmRNA结合蛋白-3在结肠癌中的表达与临床意义. 中华实验外科杂志,2010;27(8):1046-1048.
9、Li D, Yan D*, Tang H, Zhou C, Fan J, Li S, Wang X, Xia J, Huang F, Qiu G, Peng Z. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis. Ann Surg Oncol,2009;16(12):3499-3506.
|
